| ABBVIE | Spain |
| AbbVie Deutschland GmbH & Co KG | Germany |
| Advent France Biotechnology | France |
| Alta Life Sciences | Spain |
| ARCH Venture Partners | United States |
| Asabys Partners | Spain |
| Aurora Science | Italy |
| Bayer | Spain |
| BME Growth | Spain |
| Boehringer Ingelheim Pharma | Germany |
| Caixa Capital Risc | Spain |
| Capital Cell | Spain |
| Clave Mayor | Spain |
| Columbus Venture Partners | Spain |
| CR Ventures | United States |
| ECBF – European Circular Bioeconomy Fund | Germany |
| Euronext | France |
| Forty51ventures | Switzerland |
| Fund+ | Belgium |
| Grifols, S.A. | Spain |
| Inveready | Spain |
| InVivo Capital | Spain |
| IPF Partners | Switzerland |
| Keensight Capital | France |
| Kurma Partners | France |
| Merck Ventures Bv | Netherlands |
| MSD | United Kingdom |
| Norgine Ventures | United Kingdom |
| Nowture | Spain |
| Omnes Capital | France |
| Remiges Ventures | United States |
| Sanofi-Aventis Deutschland GmbH | Germany |
| Seventure | France |
| Sodena | Spain |
| Ultreum Life Science Dmcc | United Arab Emirates |
| Unirisco Galicia SCR | Spain |
| Ventac Partners | Spain |
| Wellington Partners | Germany |
| Ysios Capital Partners | Spain |
